Discussion emerged soon after a proposal for the first OTC daily oral contraceptive in the US was announced on whether approval would swing on influences other than the drug’s safety and efficacy for use without the intervention of a medical professional.
Prevalent in the discussion are mentions of HRA Pharma’s new drug application for OTC 0.075-mg norgestrel emerging soon after a...







